Inactive Instrument

Kun Run Biotechnology, Inc. Stock

Equities

Duration

Period

Style

KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration	10-06-17	PR
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement	10-04-22	PR
KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results	10-03-30	PR
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results	09-11-13	PR
KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million	09-04-01	PR

Sector

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.08%	44.25B
OTSUKA HOLDINGS CO., LTD.	+19.80%	22.33B
CIPLA LIMITED	+10.34%	13.36B
SANDOZ GROUP AG	+3.22%	13.24B
ZYDUS LIFESCIENCES LIMITED	+37.09%	11.27B
ONO PHARMACEUTICAL CO., LTD.	-6.38%	7.15B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.00%	5.24B